Market Research Blog – Page 9145 – New Product Development

Global Intradermal Injection Market Demand: Strong Pipeline to Rapidly Surge Growth

The global Intradermal Injection Market is expected to exceed an impressive valuation of US$ 3,878 Million in 2022, with a compound annual growth rate (CAGR) of 10.8% projected from 2022 to 2032. Technological advancements in recent years have resulted in the development of surgical approaches with the goal of minimising waste and achieving better results. Reusable intradermal devices result in low waste generation, which has a net positive effect on an economy’s productivity.

Request Sample@ https://www.futuremarketinsights.com/reports/sample/rep-gb-15855

Furthermore, the findings of several meta-analyses show that intradermal drug delivery reduces the severity of adverse events. The aforementioned factors point to a favourable future environment for this segment’s rapid growth. The rising prevalence of tuberculosis is expected to boost the intradermal injection market’s growth rate. According to WHO data, tuberculosis is the 13th leading cause of death, with approximately 10 million cases of TB recorded each year, resulting in a dramatic increase in the diagnostic rate of TB over the last decade.

This is one of the major factors contributing to the growth of the intradermal injection market for tuberculin syringes. The American Cancer Society’s 2022 report predicts that over 1.9 million new cancers will be diagnosed in the United States in 2022. According to the same source, the risk of developing cancer increases dramatically with age, with 80% of cancer patients in the United States being 55 or older, and 57% being 65 or older. According to these figures, the growing geriatric population is expected to have a significant positive impact on market growth.

Key Takeaways from Market Study

The global Intradermal Injection market is expected to be worth $10,814.47 million.
From 2022 to 2032, the market is expected to grow at a compound annual growth rate (CAGR) of 10.8%.
The Europe Intradermal Injection market is expected to grow significantly, with the United Kingdom acquiring a sizable share.
In terms of revenue and market share, North America was the most profitable regional segment.
Normal sized needles dominate the market in terms of method.
The tuberculin skin test segment is estimated to have the largest share by application.

“The growing burden of chronic diseases has led to a rise in the overall use of syringes, particularly disposable syringes, intradermal jet injectors, microinjections, and ballistic intradermal injections treatment and diagnostic purposes,” says an analyst at Future Market Insights.

Ask an Analyst@ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-15855

Key Market Players

Major players are channeling efforts toward expanding their production capacities to strengthen their market share and cater to the growing demand. Market expansion is anticipated to be aided by the growing number of partnerships and collaborations among key players that are looking to increase their presence in the market. Key players in the Intradermal Injection market are Becton Dickinson, Cardinal Health, West Pharmaceuticals services, Terumo Corporation, Nanopass, Pharmajet, Idevax, Enusung, Crossject, and Hindustan Syringes and Medical Devices.

Stevanato Group S.p.A. signed an exclusive agreement for its Aidaptus auto-injector with leading medical device developer and manufacturer Owen Mumford Ltd. in May 2022. Aidaptus is a two-step, single-use auto-injector with a flexible design that can hold both 1 mL and 2.25 mL prefilled glass syringes in the same base device.
Takeda Pharmaceutical Company Limited received European Commission approval for the subcutaneous (SC) formulation of Entyvio (vedolizumab), a gut-selective biologic intended for use as maintenance therapy in adults with moderately to severely active ulcerative colitis (UC) or Crohn’s disease, in May 2020. (CD). Entyvio SC is available as a pre-filled syringe as well as a pre-filled pen.
Terumo Corporation is a forerunner in hypodermic needle development. The company provides a comprehensive platform of precision-engineered needle and needle stick prevention technologies, which are ready for the most difficult applications and high-throughput processing environments. To ensure the therapeutic success of the drug product, the company assists in the design and delivery of safer, less painful injections. The Nanopass® 34G Needle for Pen Injectors, the Neolus Needles, the SurGuard® Safety Hypodermic Needles, the SurGuard® 3 Safety Hypodermic Needles, and the Terumo 3-Part Syringe are among its products.
Crossject announced an expansion of its partnership with long-term collaborator Cenexi in May 2021 to ramp up industrial scale manufacturing of the ZENEO® needle-free auto-injection. Cenexi strengthened its position on innovation and sterile manufacturing expertise with this announcement, owing to its human-scale agility and recognised skills in pharmaceutical development.

Buy Now@ https://www.futuremarketinsights.com/checkout/15855

More Valuable Insights

Future Market Insights, in its new offering, presents an unbiased analysis of the global Intradermal Injection market, presenting historical analysis from 2017 to 2021 and forecast statistics for the period of 2022-2032.

The study reveals essential insights on the basis of Method (Normal Sized Needles, Short Needle (Intradermal Microinjection, Microneedle Arrays, and Tattoo Devices], and Without Needle {Intradermal Liquid Jet Devices and Ballistic Intradermal Injectors]), Application (Tuberculin Skin Test, Allergy Test, Local Aesthetics, and Others), and End User (Hospitals, Diagnostic Laboratories, Academics and Research Institutes, and Others) & Region.

About the Technology at Future Market Insights

The healthcare team at Future Market Insights offers expert analysis, time-efficient research, and strategic recommendations with an objective to provide authentic insights and accurate results to help clients worldwide. With a repertoire of over 100+ reports and 1 million+ data points, the team has been analyzing the industry lucidly in 50+ countries for over a decade. The team provides a brief analysis of key trends including competitive landscape, profit margin, and research development efforts.

About Future Market Insights (FMI)

Future Market Insights (ESOMAR certified market research organization and a member of Greater New York Chamber of Commerce) provides in-depth insights into governing factors elevating the demand in the market. It discloses opportunities that will favor the market growth in various segments on the basis of Source, Application, Sales Channel and End Use over the next 10-years.

Contact:

Future Market Insights, Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Browse All Reports: https://www.futuremarketinsights.com/reports
LinkedIn| Twitter| Blogs

Intrathecal Pumps Market Size is set to Grow at a Remarkable Pace in the Coming Years

According to Future Market Insights (FMI), the global Intrathecal Pumps Market was valued at US$ 221.1 Mn in 2021 and is expected to reach US$ 383.5 Mn by 2032. According to the report’s findings, revenue from Morphine Intrathecal Pumps is expected to reach US$ 116 Mn by 2032, growing at a 4.8% CAGR during the forecast period.

According to Boston University’s School of Public Health, there are approximately 1.5 billion chronic pain cases worldwide, with the prevalence increasing with age. According to the Centers for Disease Control and Prevention, approximately 50 million Americans suffer from chronic pain, with 20 million suffering from severe chronic pain. These figures are increasing, which is helping to drive the intrathecal pump market forward.

Request Sample@ https://www.futuremarketinsights.com/reports/sample/rep-gb-15852

The United States will hold the largest share of the market throughout the Analysis Period

The Intrathecal Pumps Market in the United States is expected to grow at a CAGR of 5.2% between 2022 and 2032. The intrathecal pump market grew at a 3.5% CAGR from 2017 to 2021. According to the American Cancer Society, over 24 thousand people in the United States will have a malignant tumour of the brain or spinal cord in 2021.

According to a recent report published by the WHO’s International Agency for Research on Cancer, there are now significantly more cancer patients. According to estimates, there are approximately 14.1 million cancer patients. Furthermore, it was determined that 8.2 million people will die from cancer each year. Because of the increase in cancer cases, the market for intrathecal pumps is expected to grow in the future.

Intrathecal Pumps Market: Competition Insights

Some of the key companies operating in the Intrathecal Pumps Market include Medtronic, Smiths Medical, Flowonix Medical Inc., tricumed Medizintechnik GmbH, Teleflex Incorporated, Johnson and Johnson Services, Inc., Durect Corporation, Medallion Therapeutics, Inc., Abbott, Baxter International Inc., Codman & Shurtleff, Inc., DePay Synthes, Summit Medical Group, B Braun Melsungen AG, Becton, Dickinson & Company and Fresenius Medical Care AG & Co. KGaA., and Zimmer Biomet.

Contact our Market Research Specialist@ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-15852

Some of the recent developments by key providers of the Intrathecal Pumps Market are as follows:

Flowonix Medical, a medical device company based in the United States that specialises in implanted medication delivery systems, received a US$ 33 million award in January 2021. SWK Holdings (SWKH), a specialised finance firm that works with small and mid-sized commercial-stage life-science enterprises, provided a US$ 10 million debt facility as part of the deal.
Baxter International Inc. issued an urgent device correction for all of its spectrum infusion pumps in October 2020 to reinforce safety advice regarding proper pump cleaning procedures. Failure to follow the cleaning procedures reduced the pumps’ efficiency and effectiveness.
In February 2020, a 40 ml pump for intrathecal drug delivery was introduced by Flowonix Medical. It uses a pressure-driven, valve-gated delivery mechanism and has a battery life of more than 10 years, reducing the need for additional surgical procedures.

Key Segments Covered in Intrathecal Pumps Market Survey

By Type:

Baclofen
Bupivacaine
Clonidine
Morphine
Ziconotide
Other Types

By Application:

Spasticity
Pain

Buy Now@ https://www.futuremarketinsights.com/checkout/15852

More Insights Available

Future Market Insights, in its new offering, presents an unbiased analysis of the intrathecal pumps market, presenting historical market data (2017-2021) and forecast statistics for the period of 2022-2032.

The study reveals essential insights by Type (Baclofen, Bupivacaine, Clonidine, Morphine, Ziconotide, and Other Types), By Application (Spasticity and Pain), across five regions (North America, Latin America, Europe, Asia Pacific, and Middle East & Africa).

About Future Market Insights (FMI)

Contact:

Terahertz Technology Market to Etch New Growth Ratio with Adoption in Developing Economy

According to FMI, the global Medical Terahertz Technology Market will be worth US$ 135.29 billion in 2022. During the forecast period, it is expected to grow at a CAGR of 17.1%, reaching a value of US$ 768.05 Mn by 2032.

Because of its applications in biology and medicine, medical imaging, spectroscopy of materials, sensing, security, monitoring, and spectroscopy, as well as applications in sensing, security, monitoring, and spectroscopy, terahertz technology is driving market growth within the pharmaceutical industry.

Request Sample@ https://www.futuremarketinsights.com/reports/sample/rep-gb-15849

Furthermore, due to its high power and picosecond pulse time structure, the Terahertz free-electron laser (FEL) is a powerful and adaptable source of coherent radiation for THz pulsed imaging, enabling market growth.

” In the pharmaceutical industry, terahertz technology is a fast-growing field that is driving market growth due to its applications in biology and medicine, medical imaging, material spectroscopy, and sensing, security, monitoring, and spectroscopy, as well as applications in sensing, security, monitoring, and spectroscopy. This will create ample growth opportunities for the market,” says a lead analyst at FMI

Key Takeaways from the Medical Terahertz Technology Market

The global terahertz imaging market is expected to generate US$ 273.77 million by 2032, growing at a CAGR of 23.1%.
North America is expected to retain the largest market share and grow at a fast-paced CAGR of 21.6%.
By 2032, Europe could contribute US$ 290.88 Mn to the medical terahertz technologies market.
The Asia Pacific region is expected to experience the fastest market growth, as China plans to modernise its economic infrastructure and expand the number of industries.

For More Insights, Contact@ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-15849

Competition Landscape in the Medical Terahertz Technology Market

The global terahertz imaging market is expected to generate US$ 273.77 million by 2032, growing at a CAGR of 23.1%.

North America is expected to retain the largest market share and grow at a fast-paced CAGR of 21.6%.

By 2032, Europe could contribute US$ 290.88 Mn to the medical terahertz technologies market.

The Asia Pacific region is expected to experience the fastest market growth, as China plans to modernise its economic infrastructure and expand the number of industries.

Acal Bfi Limited, Advantest Corporation, Teraview limited, Luna Innovations Inc., Insight Product Company, and Toptica Photonics AG are some of the key players operating the global medical terahertz technology market.

Recent Developments in the Medical Terahertz Technology Market

In April 2022, Advantest Corporation released Euclid, a 3D image viewer for its photoacoustic microscopes. Tomographic images are easily generated, and 3D images are automatically displayed by superimposing data from a Hadatomo tool on skin melanin, vascular network, and skin structure. This product is used in dermatological research for both cosmetic and medical purposes.
TeraSense announced in April 2022 the release of its IMPATT-based generator, a powerful wave source with an output power ranging from 0.08 watts to 1.8 watts.
In February 2022, researchers at the Korea Institute of Science and Technology (KIST) investigated the use of label-free THz metamaterials for rapid and accurate discrimination of Covid-19 virus variants. Label-free THz metamaterials are used to detect Covid-19 virus protein units in this type of virus detection known as biomarker detecting technology.
In October 2021, Menlo Systems opened a branch in China, Shanghai Menlo Systems Quantum Laser Technology Co., Ltd. As a result, the company will be able to strengthen its position in China’s thriving photonics market. Menlo Systems offers a variety of ultra-stable lasers, terahertz systems, and femtosecond lasers.

Customization Available@ https://www.futuremarketinsights.com/customization-available/rep-gb-15849

Medical Terahertz Technology Market by Category

By Type, Medical Terahertz Technology Market is Segmented as:

Terahertz Imaging
Terahertz Spectroscopy

By Application, the Medical Terahertz Technology Market is Segmented as:

Dentistry
Oncology
Dermatology
Tomography
Biochemistry
Other

About Future Market Insights (FMI)

Contact:

Medical Automation Systems Market Upcoming Trends and Analysis Report 2023-2033

The global Medical Automation Market is expected to surpass an impressive USD 44.45 billion in 2022, with a compound annual growth rate (CAGR) of 10.6% from 2023 to 2033.

The rising prevalence of chronic diseases such as cancer, diabetes, and others, the expanding pharmaceutical and biotechnology sector, and rising demand for robotic surgery, as well as rising healthcare expenditure, are the major drivers driving market growth. However, the high cost of automation and the risks associated with robotic surgery, followed by the requirement of physician training, are expected to limit market growth. The advantages associated with automated systems are attributed to the increasing adoption of these devices.

Request Sample@ https://www.futuremarketinsights.com/reports/sample/rep-gb-397

Automation of tedious tasks such as sampling, quality and quantity monitoring, packaging and labelling, and scanning of medicines and devices, for example, has condensed human efforts and increased speed and accuracy, leading to increased reliance on these automated systems. Furthermore, the growing global prevalence of chronic conditions such as diabetes, cancer, arthritis, and chronic obstructive pulmonary disease (COPD) is driving demand for faster and more productive therapeutic, laboratory, and pharmacy-automated medication systems.

Key Takeaways-

North America dominated the healthcare automation market in 2021, accounting for the largest market share.
The therapeutic automation segment has the largest market share in the global market and is expected to maintain its dominance throughout the forecast period.
The Research Institute segment has the largest market share in the global market based on end users.
North America has the largest market share (41% in the global healthcare automation market) by region.
However, Asia-Pacific is expected to be the fastest-growing medical automation market.

Contact our Market Research Specialist@ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-397

Recent Developments-

In Jan 2022, medical technology industry Becton, Dickinson, and Company declared acquisition with Parata systems for more than $1.5 billion. Parata systems offer automation products for pharmacies like inventory management software, the high-speed robotic process for medical automation, robotic dispensers, workflow solutions, and adherence packaging tools. The Becton, Dickinson company’s acquisition purpose is to operate pharmacies for people’s healthier lives.
In 2021, Siemens Healthineers AG acquired Varian Medical Systems, Inc. This is a German medical device company that allows the earlier to increase access to the latter’s comprehensive portfolio as well as strengthen its position in the MedTech sector.
In 2021, Philips acquisition with Capsule Technologies, Inc. They are providers of medical device integration and data technologies for hospitals and healthcare organizations. The purpose is to enlarge Philips’s leadership in patient care management solutions. Capsule Technologies, Inc is providing medical device Information platforms such as device integration, clinical surveillance services, and vital signs monitoring. Philips’s strategy is to transform the delivery of healthcare in the health field with integrated solutions. It helps to connect almost all medical devices as well as EMRs in hospitals.

Competitive Landscape-

The major players in the medical automation market are-

Accuray, Inc.
Tecan Group Ltd.
Medtronic Plc.
Swisslog Holding AG
GE Healthcare
Intuitive Surgical, Inc.
Stryker Corporation
Siemens AG
Koninklijke Philips N.V.
Danaher Corporation
Zimmer Biomet

Request Customization@ https://www.futuremarketinsights.com/customization-available/rep-gb-397

Key Segments Profiled in the Medical automation market Survey

By Application:

Imaging
therapeutic
laboratory and pharmacy
medical software
Informatics
logistics

By end use:

Hospital and diagnostic center
Research laboratories & institutes
Pharmacies
Others

About Future Market Insights (FMI)

Contact:

Helicobacter Pylori Non-Invasive Testing Positioning and Growing Market Share Worldwide

The global Helicobacter Pylori Non-Invasive Testing Market is expected to grow at a moderate 4.4% CAGR during the forecast period. The non-invasive helicobacter pylori testing market is currently valued at US$ 650.50 Mn in 2023. The demand for helicobacter pylori non-invasive testing is expected to reach $1 billion by 2033.

The increasing prevalence of Helicobacter pylori bacterial infection, increased governmental awareness about infection for accurate diagnosis, and the launch of new products and approval of those products by the Food and Drug Administration are expected to drive the growth of the helicobacter pylori non-invasive testing market. Although there is potential for helicobacter pylori non-invasive testing demand, it is unlikely to materialise due to issues such as a low detection rate, the absence of any outward symptoms, and stringent regulatory constraints. Nonetheless, doctors have advised patients to seek treatment for H. Despite the lack of evidence linking COVID-19 and the virus, Pylori infections should be treated as soon as possible.

Request Sample@ https://www.futuremarketinsights.com/reports/sample/rep-gb-15823

North America has the largest market share for non-invasive Helicobacter pylori (H. pylori) testing, while Asia-Pacific has the fastest growth. The North American helicobacter pylori non-invasive testing market is expected to expand throughout the forecast period, owing to rising rates of gastric cancer, duodenal ulcers, and gastric ulcers, as well as improvements in healthcare infrastructure.

Throughout the forecast period, the market for non-invasive H. pylori is expected to spread fastest in Asia Pacific. China, India, and Japan are just a few of the countries in the region where non-invasive helicobacter pylori testing is expected to grow rapidly in the coming years. As Asia and the Pacific’s population ages, so does the prevalence of Helicobacter pylori (H. pylori) and gastric cancer cases, so does the market for non-invasive H. pylori testing. pylori is expected to spread. That is why there is so much room for growth in the region for helicobacter pylori non-invasive testing market players throughout the forecasted expansion period.

Key Takeaways

The rise in non-invasive testing for Helicobacter pylori (H. pylori) is expected to drive demand for H. pylori non-invasive tests. pylori diagnosis and a scarcity of endoscopic resources
The demand for non-invasive helicobacter pylori (H. pylori) testing is increasing due to increased government awareness of infection and the need for accurate diagnosis, rising demand for point-of-care testing equipment, and the widespread availability of diagnostic tests.
The demand for helicobacter pylori (H. pylori) non-invasive testing is expected to rise as a result of factors such as the increasing prevalence of H. pylori. pylori infection, the introduction of new products, and the Food and Drug Administration’s approval of these products
The global ageing population and the rising number of people with stomach ulcers are expected to fuel the growth of the helicobacter pylori non-invasive testing market.
The adoption of non-invasive testing for helicobacter pylori (H. pylori) is expected to grow during the projected period due to rising technical developments and an increase in innovations.
The demand for non-invasive tests to identify helicobacter pylori (H. pylori) is projected to face challenges such as a low detection rate, the fact that H. pylori infection often has no symptoms, and strict regulatory regulations.

Ask an Analyst@ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-15823

Competitive Landscape

The global helicobacter pylori non-invasive testing market comprises of the following players: Meridian Bioscience, Inc., DiaSorin S.p.A, Alere, Sekiusi Diagnostics and Biomerica, Inc. Besides these, a host of other players have a significant market presence as well. These are Biohit Oyj, Exalenz Bioscience Ltd., Aalto Bio Reagents Ltd., Certest Biotec S.L. and CorisBioconcept SPRL.

Recent Developments

Meridian Bioscience, Inc. has received FDA approval to market its novel Curian and Curian HpSA assays in March 2020. The new analyzer and preliminary assay are critical components of their strategy to maintain market dominance in gastrointestinal disease testing.

Thermo Fischer Scientific, a world-renowned provider of clinical research services to the biopharma and biotech industries, announced in December 2021 that it is expected to acquire PPD, Inc. for US$17.4 billion.

Key Segments in the Helicobacter Pylori Non-Invasive Testing Market

By Non-invasive Test Type:

Serology Test
Stool Antigen Test
Urea Breath Test

By Test Type:

Laboratory-based Tests
Point-of-Care Tests

By End-user:

Hospitals
Diagnostic Labs
Clinics

Buy Now@ https://www.futuremarketinsights.com/checkout/15823

About Future Market Insights (FMI)

Contact:

Lyophilized Injectable Market | Cost Structure Analysis and Forecast to 2033 – By FMI

The global Lyophilized Injectable Market is expected to grow at a steady 5.8% over the next few years. In 2023, the lyophilized injectable market is expected to be worth $3043.55 million. Demand for lyophilized injectables is expected to reach a peak of US$ 5348.56 Mn by 2033.

Because of their stability at room temperature, lyophilized medications are becoming increasingly popular. They are also ready for use after a brief rehydration procedure. As a result, using this method streamlines and simplifies procedures while also lowering the likelihood of making numerous pipetting errors. Because of all of these advantages, the global lyophilized injectable market is expected to grow in the coming years.

Request Sample@ https://www.futuremarketinsights.com/reports/sample/rep-gb-15815

The rise in chronic diseases is a significant factor driving up demand for these medicines. There has been a significant decrease in the number of people suffering from heart disease, kidney disease, cancer, and diabetes over the last ten years. All of these diseases have been linked to a decrease in physical activity and an increase in processed foods. Concerns about young adults developing chronic diseases have grown as more of them consume alcohol and smoke tobacco. The packaging used to store injectable medications is one of the most important aspects of lyophilizing them. Even if it occurs only infrequently, lyo-breakage has a significant impact on operations and costs. This has piqued the interest of key players in the global lyophilized injectable market in the possibility of using different vial designs in their plans to reduce the risk of lyo-breakage. Businesses can now move vials into and out of the lyophilizer without using a lot of side-load force.

Lyophilization is a critical process that necessitates the use of a wide range of expensive tools. Manufacturers are focusing on lowering the peak vertical load when the stopper is closed to prevent lyo-breakage.

Key Takeaways

In 2022, the injection supplies drugs market held more than 29% of the business share, with the prefilled diluent syringes segment accounting for more than 29% of the business share.
The market for online pharmacies is expected to generate more than US$ 34 billion by 2022. The COVID-19 pandemic is a major factor driving a steady shift away from physical pharmacies and toward online e-commerce websites. This shift is expected to contribute to the growth of online platforms.
In 2022, the lyophilized injectable market in North America will account for more than 47 percent of total revenue.
In 2022, the segment of antiarrhythmic drugs accounted for more than US$19 Bn in revenue. The growing incidence of cardiovascular diseases across the globe is one of the primary contributors to the skyrocketing demand for these medications.

Ask an Analyst@ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-15815

Competitive Landscape

Companies that play a crucial role in meeting the global demand for lyophilized injectables are becoming increasingly interested in making drug delivery systems that can be used with any drug, can be updated, and changed. To reach their objective, they are investing heavily in R&D-related activities.

Key players in the injection supplies industry rely on a strategy of continuous product development and improvement to meet the needs of customers all over the world and keep their place in the highly competitive global lyophilized injectable market. For instance, in April 2022, Recipharm acquired the Contract Development and Manufacturing Organisation (CDMO) services of both Arranta Bio, a leader in advanced therapy, and Vibalogics, a pioneer in virotherapy. Recipharm’s new facilities in Boxborough, Massachusetts gives the company a solid footing in the United States and pave the way for future growth into new areas of biologics therapy.

Key Segments in the Lyophilized Injectable Market

Packaging:

Single-Use Vials
Point-of-Care Reconstitution
Specialty Packaging

Type of Delivery:

Prefilled Diluent Syringes
Single-Step Devices
Proprietary Reconstitution Devices
Multi-Step Devices

Indication:

Metabolic and Oncology Conditions
Infectious Diseases
Autoimmune Diseases
Others

End User:

Hospitals
Ambulatory Surgical Centers
Specialty Clinics
Others

Buy Now@ https://www.futuremarketinsights.com/checkout/15815

About Future Market Insights (FMI)

Contact:

HPV Testing and Pap Test Market | Global Industry Analysis and Opportunity Assessment 2022-2032

According to a recent market survey conducted by Future Market Insights (FMI), the Global HPV testing and Pap Test Market was valued at US$ 2.2 billion in 2021 and is expected to reach US$ 15 billion by 2032. According to the report’s findings, Pap Testing will continue to be crucial for the market, as it will generate the majority of revenue, with a CAGR of 17.5%. Official strategies and policies, such as the WHO global cervical cancer elimination strategy, are expected to increase demand for testing. New technologies, government programmes, and public awareness campaigns will all help to increase demand in low-resource areas.

Request Sample@ https://www.futuremarketinsights.com/reports/sample/rep-gb-15811

Cervical Cancer Screening to Continue being the key application for HPV and Pap Test Revenue

Vaginal cancer cannot be detected solely through Pap or HPV tests. However, they can detect cervical cancer, HPV, and pre-cancerous conditions. This is useful because the presence of these can be a risk factor for cervical cancer.

The US to Command the Larger Proportion of HPV testing and Pap test consumption in the Analysis Period

The United States contributed the most to the increase in demand for HPV and Pap tests. The American Cancer Society recommends screening women over the age of 25 at recommended intervals. There are also programmes that offer free or low-cost testing to women, such as the CDC’s NBCCEDP.

HPV testing and Pap Test Market: Competition Insights

HPV Testing and Pap Test providers are focused on increasing the efficiency, accuracy and affordability of their tests and harnessing new technology. The key companies operating include Abbott Laboratories, Qiagen N.V., Becton, Dickinson and Company, Quest Diagnostics, Inc., Hologic, Inc., F. Hoffmann-La Roche, Femasys, Inc., Arbor Vita Corporation, NURX, Inc., Seegene, Inc., Thermo Fisher Scientific. Inc., bioMérieux SA

Some of the recent developments in HPV Testing and Pap Test are as follows:

in June 2022 Hoffmann-La Roche AG, a Swiss healthcare pharmaceutical and diagnostics company, announced the launch of a self-sampling solution that allows patients to collect samples privately at a healthcare facility and have them analysed. The goal of allowing self-collection was to offer an alternative to the traditional invasive clinician-based collection process.
Alercell, Inc, a molecular diagnostics company and diagnostics provider, announced the “Meltpro HPV genotype test” in May 2022. It is based on DNA sequencing research. The use of a PCR machine eliminates the risk of human interpretation and results in less than three hours.
In June 2022, Karkinos Healthcare, which operates in the oncology healthcare sector, developed CerviRaksha, a clinically validated HPV test that has been pre-qualified and approved by the World Health Organization (WHO) and the United States Food and Drug Administration (FDA). It has also been granted the CE mark and bears it. The samples are collected at home, and the results are sent via email. Individual HPV-16 and HPV-18 genotypes are distinguished, and false positives are filtered.
In May 2022, The London School of Hygiene and Tropical Medicine and the University of Manchester, and the University of Hull will collaborate to test for cervical cancer in women of the 65-and-older age group, who are often overlooked despite accounting for over 50% of cervical cancer incidents in the UK. This test will also only require a urine sample, which may entice women who were previously refusing to participate.

Ask an Analyst@ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-15811

Key Segments Covered in HPV Testing and Pap Test Survey

HPV Testing and Pap Test Market by Type:

HPV Testing
Pap Test

HPV Testing and Pap Test Market by Application:

Vaginal Cancer Screening
Cervical Cancer Screening

HPV Testing and Pap Test Market by Product Type:

Instruments
Consumables
Services

HPV Testing and Pap Test Market by Technology:

PCR
Immunodiagnostics
Other Technologies

Request Customization@ https://www.futuremarketinsights.com/customization-available/rep-gb-15811

More Insights Available

Future Market Insights, in its new offering, presents an unbiased analysis of the HPV Testing and Pap Test Market, presenting historical market data (2017-2021) and forecast statistics for the period of 2022-2032.

The study reveals essential insights on the basis of by Test Type (HPV Testing, Pap Test), By Application (Vaginal Cancer Screening, Cervical Cancer Screening), By Product Type (Instruments, Consumables, Services), by Technology (PCR, Immunodiagnostics, Other Technologies), across five regions (North America, Latin America, Europe, Asia Pacific and Middle East & Africa).

About Future Market Insights (FMI)

Contact:

Bone Grafts and Substitutes Market Growth, Regional Analysis, Trends and Forecast 2022-2032

According to a recent market survey conducted by Future Market Insights (FMI), the global Bone Grafts and Substitutes Market was valued at $2.9 billion in 2021 and is expected to reach $6.3 billion by 2032. According to the report’s findings, the spinal fusion segment by deployment mode will continue to be critical for the market, as it will generate the majority of revenue. According to the deployment model, the spinal fusion segment will account for a CAGR of 6.9% in 2032. The increasing number of SCI cases worldwide, which is a major factor in the high demand for bone grafts and substitutes in the spinal fusion segment.

Request Sample@ https://www.futuremarketinsights.com/reports/sample/rep-gb-15798

The US to Command the Larger Proportion of Bone Grafts and Substitutes Market throughout the Analysis Period

The United States controls 37.3% of the market and is expected to maintain its position with an absolute opportunity growth of US$ 1.2 billion to reach a valuation of US$ 2.4 billion by 2032. Its demand in the United States is expected to rise due to the rapidly increasing demand for bone grafts and substitutes in Spinal Cord Injuries (SCIs). According to the CDC, 67 million adults in the United States will have arthritis by 2030, increasing the demand for bone grafts, which are required for arthritis treatment.

“The application of allograft bone grafts in demineralized bone matrices procedures have significant potential to emerge as a key market driver during the forecast period for the Bone Grafts and Substitutes market.” comments an analyst at Future Market Insights.

Bone Grafts and Substitutes Market: Competition Insights

Currently, Bone Grafts and Substitutes providers are largely aiming at adopting strategies such as mergers, acquisitions, and partnerships. They are working towards finding a balance between expanding their product portfolio and capitalizing on the growing market demand. The key companies operating in the Bone Grafts and Substitutes market include Allosource, DePuySynthes Inc., Baxter, NuVasive Inc., Smith & Nephew, Medtronic, Orthofix Holdings Inc., TBF Tissue Engineering, Stryker Corporation, OrthoFix Medical Inc., MedBone Biomaterials, and SeaSpine.

Contact our Market Research Specialist@ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-15798

The key recent developments of Bone Grafts and Substitutes manufacturers are as follows:

Orthofix Medical Inc. launched Opus B.A., a highly efficient and synthetic bioactive bone graft solution, in February 2022 to aid in the process of cervical and lumbar spine fusions.
NuVasive Inc. acquired Simplify Medical in February 2021 to strengthen the company’s cervical portfolio, thereby expanding its growth avenues during the forecast period.
Wright Medical Group N.V. will be acquired in November 2020. Stryker Corporation completed the project. The acquisition of this medical equipment company specialising in extremities and biologics is expected to help Stryker Corporation improve its bone graft substitute portfolio and expand its market position.
Baxter’s Altapore Shape bioactive bone graft was approved by the FDA in July 2020. Among the many benefits of this bone graft is improved bone growth.

Key Segments Covered in Market Survey

The Bone Grafts and Substitutes Market is segmented based on material type, deployment mode and region.

By Material Type:

Allograft
- Demineralized Bone Matrix
- Other Allografts
Synthetic
- Ceramics
- Composites
- Polymers
- Bone Morphogenic Proteins (BMP)

By Deployment Mode:

Craniomaxillofacial
Dental
Foot & Ankle
Joint Reconstruction
Long Bone
Spinal Fusion

Buy Now@ https://www.futuremarketinsights.com/checkout/15798

More Insights Available

Future Market Insights, in its new offering, presents an unbiased analysis of the Bone Grafts and Substitutes Market, presenting historical market data (2017-2021) and forecast statistics for the period of 2022-2032.

The study reveals extensive growth in the Bone Grafts and Substitutes Market in terms of Material Type (Allograft and Synthetic), Deployment Mode (Craniomaxillofacial, Dental, Foot & Ankle, Joint Reconstruction, Long Bone, and Spinal Fusion), and across five regions (North America, Latin America, Europe, Asia Pacific and Middle East & Africa).

About Future Market Insights (FMI)

Contact:

Global Pulse Oximeter Market Projected to Gain Significant Value through 2022-2032

According to a recently published Future Market Insights report, the Pulse Oximeter Market is expected to grow at a CAGR of 7.6% between 2022 and 2032, with revenues estimated at US$ 2.3 billion in 2021. The market is expected to be worth US$ 5.1 billion by the end of 2032.

Request Sample@ https://www.futuremarketinsights.com/reports/sample/rep-gb-11194

The key product for Pulse Oximeter is handheld pulse oximeter, and the demand for Pulse Oximeter through handheld pulse oximeter was recorded at 7.4% between 2017 and 2021, with a CAGR of 7.6% expected between 2022 and 2023.

The pulse oximeters market is being driven by the Covid-19 pandemic. Bloomreach, an e-commerce software company, reports a 527% increase in US sales of fingerprint pulse oximeters during the week of January 2020 in the US. Midway through February, it began to rise again, and weekly sales have risen since then, despite a slower rate of decline.

According to Google Trends, there had been an increase in searches for “pulse oximeter coronavirus” on Google since the middle of February. Customers purchased several personal diagnostic and health monitoring devices throughout the course of four months in April 2020, according to Snapdeal India. The most demanding ones include glucometers, blood pressure monitors, digital thermometers, and pulse oximeters. At-home diagnostic kits have shown an increase in demand after March 2020, not just on Snapdeal but also on Flipkart. Due to the COVID-19 outbreak, which necessitates their use to ensure safety, Flipkart has observed an increase in demand for these products. According to flipkart, the demand for pulse oximeters has grown by a factor of about 23. The product’s premium market segment has also experienced significant growth.

Competitive Landscape

The key companies in Pulse Oximeter Market are focused on alliances, technology collaborations, and product launch strategies. The Tier 2 Players in the market are targeting to increase their market share.

Contact our Market Research Specialist@ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-11194

Some of the recent developments of key Neural Implants providers are as follows:

Smart Meter, a manufacturer of patient monitoring equipment, has announced the release of iPulseOx in March 2022. The first cell phone-connected pulse oximeter provides remote patient monitoring for chronic diseases such as heart disease and chronic obstructive pulmonary disease (COPD). This product launch has enhanced the company’s standing by providing them with a competitive technological advantage over their competitors and expanding their customer base.
DetelPro announced the release of the Oxy10 pulse oximeter in June 2021. The results of this product can be determined by using an LED display. Because of this product launch, the company’s pulse oximeter portfolio was expanded across numerous hospitals and homecare facilities, resulting in increased revenue.
Masimo acquired LiDCO, a provider of noninvasive and minimally invasive hemodynamic technology, in February 2021, adding enhanced measuring and patient monitoring capabilities.
Tyto Care, a telehealth company, introduced a fingertip pulse oximeter that connects to the TytoCare device via a cable to log test results to patients’ EHRs and enable remote monitoring by clinicians in January 2021.
GE Healthcare increased its AI products and Edison ecosystem in November 2020 to capitalise on the digital health trend and ongoing investments in innovation. The company is also introducing cutting-edge imaging technologies.
Masimo and Royal Philips reaffirmed their partnership in May 2020, with Philips incorporating additional Masimo measurement technologies into specific IntelliVue MX-series multiparameter monitors to assist doctors in determining cerebral oximetry and ventilation status.

Pulse Oximeter Market Segmentation

By Type:

Fingertip
Handheld

By End-use:

Hospitals & Other Healthcare Facilities
Homecare

Buy Now@ https://www.futuremarketinsights.com/checkout/11194

More Insights Available

Future Market Insights, in its new offering, presents an unbiased analysis of the Pulse Oximeter Market, presenting historical market data (2017-2021) and forecast statistics for the period of 2022-2032.

The study reveals extensive growth in Pulse Oximeter in terms of by Type (Fingertip, Handheld, Other Types), By End-use in (Hospitals & Other Healthcare Facilities, Homecare) across five regions (North America, Latin America, Europe, Asia Pacific and Middle East & Africa).

About Future Market Insights (FMI)

Contact:

Laboratory Supplies Market is expected to grow significantly between 2022-2032

The global demand for Laboratory Supplies is projected to increase at a CAGR of 8% during the forecast period between 2022 and 2032, reaching a total of US$ 81.61 Billion in 2032, according to a report from Future Market Insights (FMI). From 2017 to 2021, sales witnessed significant growth, registering a CAGR of 6%.

Rise in investment for R&D activities by countries, the amalgamation of lab equipment with state-of-the-art technology, and increase in demand for plastics in the healthcare industry due to its advantages over metal and glass, which includes cost-effectiveness, lightweight, versatility, and biocompatibility, are factors driving the market.

Request Sample@ https://www.futuremarketinsights.com/reports/sample/rep-gb-15785

Laboratories have developed as multipurpose research facilities in which numerous types of testing mechanisms, research comparisons, and different developments are carried out. This has also led to a rise in the laboratory supply market demand. Moreover, the trend of lab supplies research has been gaining a strong grip over the past decade. This has resulted in the expansion of new laboratories in academic institutions, thereby driving the market growth.

Furthermore, clinical laboratories are also going through major technological developments. With intense research and development going on in the field of personalized medicine and the pathogenesis of diseases, advanced diagnostics procedures and tests are being executed widely. The technological improvements in the laboratory continue to bring real benefits that increase from greater ease of use, speed of analysis, improved safety, higher precision, increased capacity, operational efficiencies, enhanced reliability, and numerous other intangibles.

Key Takeaways from Market Study

The equipment segment dominates the market with a share of over 63.4% due to the high costs associated with them
The disposables segment is anticipated to witness a rapid growth rate of 8.3% during the forecast period as they help in avoiding contamination and reducing errors in the procedures
Among disposables, the tube segment accounts for a maximum share of 19.2%. They are mostly used in laboratories to view, store, and transport samples
North America was the leading regional segment in terms of revenue and market share.

“The demand for laboratory products is rising due to technological advancements in the field of chemical and biological research. The increasing volume of clinical laboratory tests and life science research investigations is driving the demand for laboratory disposable products,” says an analyst at Future Market Insights

Ask an Analyst@ https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-15785

Key Market Players

Major players are channelling efforts toward expanding their production capacities to strengthen their market share and cater to the growing demand. Market expansion is anticipated to be aided by the growing number of partnerships and collaborations among key players that are looking to increase their presence in the market. Some of the players in the Laboratory Supplies market are Bio-Rad Laboratories, Inc.; Bruker Corporation; Danaher Corporation; Fujifilm Holdings Corporation (Irvine Scientific Sales Company, Inc.); Agilent Technologies Inc.; and Others.

In March 2022, Precisa Gravimetrics AG introduced their Halo range of sophisticated UV-Vis spectrophotometers GB 30 under the Dynamica brand.
In February 2021, INTEGRA Biosciences launched the D-ONE single-channel pipetting module for hands-free transfers from individual tubes or wells using the ASSIST PLUS pipetting robot. This system effectively automates tedious tasks such as serial dilutions, sample normalization, hit picking, or pipetting of complex plate layouts, increasing productivity and reproducibility in the lab while reducing hands-on time, processing errors, and physical strain.

Key Segments Profiled in the Laboratory Supplies Market Industry Survey

Laboratory Supplies Market by Product Type:

Equipment
Incubators
Laminar Flow Hood
Micro Manipulation Systems
Centrifuges
Lab Air Filtration System
Scopes
Sonicators And Homogenizers
Autoclaves And Sterilizers
Spectrophotometer And Microarray Equipment
Others

Disposables
Pipettes
Tips
Tubes
Cuvettes
Dishes
Gloves
Masks
Cell Imaging Consumables
Cell Culture Consumables

Buy Now@ https://www.futuremarketinsights.com/checkout/15785

More Valuable Insights

Future Market Insights, in its new offering, presents an unbiased analysis of the global Laboratory Supplies market, presenting historical analysis from 2016 to 2021 and forecast statistics for the period of 2022-2032.

The study reveals essential insights on the basis of by Product (Equipment (Autoclaves & Sterilizers, Spectrophotometer & Microarray Equipment), Disposables (Tubes, Masks) & Region (North America, Latin America, Europe, Asia Pacific, and Middle East & Africa).

About the Healthcare at Future Market Insights

The healthcare domain team at Future Market Insights offers expert analysis, time-efficient research, and strategic recommendations with an objective to provide authentic insights and accurate results to help clients worldwide. With a repertoire of over 100+ reports and 1 million+ data points, the team has been analyzing the industry lucidly in 50+ countries for over a decade. The team provides a brief analysis of key trends including competitive landscape, profit margin, and research development efforts.

About Future Market Insights (FMI)

Contact: